|4Jul 5, 3:36 PM ET

ORAMED PHARMACEUTICALS INC. 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Jul 5, 2017

Insider Transaction Report

Form 4
Period: 2017-06-30
Transactions
  • Award

    Stock Option (right to buy)

    2017-06-30+16,77316,773 total
    Exercise: $7.77Exp: 2027-06-30Common Stock (16,773 underlying)
Footnotes (1)
  • [F1]The Stock Option will vest in 3 equal installments of 5,591 on each of December 31, 2017, December 31, 2018 and December 31, 2019.

Documents

1 file
  • 4
    f4063017friedman_oramed.xmlPrimary

    OWNERSHIP DOCUMENT